The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Open accessAbstract
Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL) cholesterol and causes premature coronary heart disease. There are at least 20 million people with FH worldwide, but the majority remain undetected and current treatment is often suboptimal. To address this major gap in coronary prevention we present, from an international perspective, consensus-based guidance on the care of FH. The guidance was generated from seminars and workshops held at an international symposium. The recommendations focus on the detection, diagnosis, assessment and management of FH in adults and children, and set guidelines for clinical purposes. They also refer to best practice for cascade screening and risk notifying and testing families for FH, including use of genetic testing. Guidance on treatment is based on risk stratification, management of non-cholesterol risk factors, and safe and effective use of LDL lowering therapies. Recommendations are given on lipoprotein apheresis. The use of emerging therapies for FH is also foreshadowed. This international guidance acknowledges evidence gaps, but aims to make the best use of contemporary practice and technology to achieve the best outcomes for the care of FH. It should accordingly be employed to inform clinical judgement and be adjusted for country-specific and local health care needs and resources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
Retracted(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
Self-citationJensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Self-citationJones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,398
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Self-citation2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160
Smith, S. C., Jr. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ahxt-ag78 · Cited by 1,042
Genetic Associations with Valvular Calcification and Aortic Stenosis
Thanassoulis, G., Campbell, C. Y., Owens, D. S., Smith, J. G., Smith, A. V., Peloso, G. M., Kerr, K. F., Pechlivanis, S., Budoff, M. J., Harris, T. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109034 · Cited by 1,008
Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M.-J., Cromwell, W. C., Lachmann, R. H., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 924
Self-citationArtinian, N. T., Fletcher, G. F., Mozaffarian, D., Kris-Etherton, P., Van Horn, L., Lichtenstein, A. H., Kumanyika, S., Kraus, W. E., Fleg, J. L., Redeker, N. S., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181e8edf1 · Cited by 919
Smilde, T., van Wissen, S., Awollersheim, H., Trip, M., Kastelein, J., & Stalenhoef, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04053-8 · Cited by 918
Self-citationKane, J. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450230043027 · Cited by 829
Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816
Anderson, T. J., Grégoire, J., Hegele, R. A., Couture, P., Mancini, G. B. J., McPherson, R., Francis, G. A., Poirier, P., Lau, D. C., Grover, S., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.032 · Cited by 770
Den Ruijter, H. M., Peters, S. A. E., Anderson, T. J., Britton, A. R., Dekker, J. M., Eijkemans, M. J., Engström, G., Evans, G. W., de Graaf, J., Grobbee, D. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.9630 · Cited by 760
Cuchel, M., Meagher, E. A., du Toit Theron, H., Blom, D. J., Marais, A. D., Hegele, R. A., Averna, M. R., Sirtori, C. R., Shah, P. K., Gaudet, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61731-0 · Cited by 744
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C. G., Liem, A. H., Heeringa, J., Witteman, J. C., Lansberg, P. J., Kastelein, J. J. P., et al. (2008) · BMJ · doi:10.1136/bmj.a2423 · Cited by 721
Self-citationLipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Diabetes Care · doi:10.2337/dc08-9018 · Cited by 707
Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., & Steinberger, J. (2006) · Circulation · doi:10.1161/circulationaha.106.179568 · Cited by 707
Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705 · cited 1×
“should not be used [8, 10, 11], particularly in younger patients, in whom a measure of long-term risk based on imaging of subclinical atherosclerosis may be more appropriate [14, 51, 52].”
BackgroundPostmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
HPS2-THRIVE Collaborative Group, Haynes, R., Jiang, L., Hopewell, J. C., Li, J., Chen, F., Parish, S., Landray, M. J., Collins, R., Armitage, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht055 · Cited by 676
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Stein, E. A., Mellis, S., Yancopoulos, G. D., Stahl, N., Logan, D., Smith, W. B., Lisbon, E., Gutierrez, M., Webb, C., Wu, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105803 · Cited by 664
National Standards for Diabetes Self-Management Education and Support
Haas, L., Maryniuk, M., Beck, J., Cox, C. E., Duker, P., Edwards, L., Fisher, E. B., Hanson, L., Kent, D., Kolb, L., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1707 · Cited by 663
Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review
Austin, M. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh236 · Cited by 657
Urbina, E. M., Williams, R. V., Alpert, B. S., Collins, R. T., Daniels, S. R., Hayman, L., Jacobson, M., Mahoney, L., Mietus-Snyder, M., Rocchini, A., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.192639 · Cited by 641
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.001 · Cited by 622
Mechanisms of disease: genetic causes of familial hypercholesterolemia
Soutar, A. K., & Naoumova, R. P. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0836 · Cited by 608
Thrombotic stroke and myocardial infarction with hormonal contraception
Lidegaard, Ø., Løkkegaard, E., Jensen, A., Skovlund, C. W., & Keiding, N. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111840 · Cited by 607
Talmud, P. J., Shah, S., Whittall, R., Futema, M., Howard, P., Cooper, J. A., Harrison, S. C., Li, K., Drenos, F., Karpe, F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62127-8 · Cited by 591
Stein, E. A., Gipe, D., Bergeron, J., Gaudet, D., Weiss, R., Dufour, R., Wu, R., & Pordy, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60771-5 · Cited by 588
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
Marks, D., Thorogood, M., Neil, H. A. W., & Humphries, S. E. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00330-1 · Cited by 570
Williams, R. R., Hunt, S. C., Schumacher, M. C., Hegele, R. A., Leppert, M. F., Ludwig, E. H., & Hopkins, P. N. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90155-6 · Cited by 566
Szczepiorkowski, Z. M., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Shaz, B. H., Weinstein, R., Wirk, A., et al. (2007) · Journal of Clinical Apheresis · doi:10.1002/jca.20129 · Cited by 546
McKenney, J. M., Koren, M. J., Kereiakes, D. J., Hanotin, C., Ferrand, A.-C., & Stein, E. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.007 · Cited by 514
Raal, F., Scott, R., Somaratne, R., Bridges, I., Li, G., Wasserman, S. M., & Stein, E. A. (2012) · Circulation · doi:10.1161/circulationaha.112.144055 · Cited by 508
Self-citationSzczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Weinstein, R., & Shaz, B. H. (2010) · Journal of Clinical Apheresis · doi:10.1002/jca.20240 · Cited by 508
Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
Civeira, F. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.010 · Cited by 495
Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands
Umans-Eckenhausen, M. A., Defesche, J. C., Sijbrands, E. J., Scheerder, R. L., & Kastelein, J. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03587-x · Cited by 489
Self-citationGagné, C., Gaudet, D., & Bruckert, E. (2002) · Circulation · doi:10.1161/01.cir.0000018744.58460.62 · Cited by 482
Self-citationSullivan, D., Olsson, A. G., Scott, R., Kim, J. B., Xue, A., Gebski, V., Wasserman, S. M., & Stein, E. A. (2012) · JAMA · doi:10.1001/jama.2012.25790 · Cited by 447
Self-citationMcKenney, J. M., Davidson, M. H., Jacobson, T. A., & Guyton, J. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.030 · Cited by 431 · cited 3×
“Neither atorvastatin, pravastatin nor pitavastatin require dose adjustments with chronic kidney disease since they are not substantially renally excreted [118, 127].”
BackgroundGiugliano, R. P., Desai, N. R., Kohli, P., Rogers, W. J., Somaratne, R., Huang, F., Liu, T., Mohanavelu, S., Hoffman, E. B., McDonald, S. T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61770-x · Cited by 428
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 426
Neil, A., Cooper, J., Betteridge, J., Capps, N., McDowell, I., Durrington, P., Seed, M., Humphries, S. E., & on behalf of the Simon Broome Familial Hyperlipidaemia Register Group (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn422 · Cited by 425 · cited 2×
“Statins reduce the risk for cardiovascular events [108-113] and”
BackgroundMcCrindle, B. W., Urbina, E. M., Dennison, B. A., Jacobson, M. S., Steinberger, J., Rocchini, A. P., Hayman, L. L., & Daniels, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.181946 · Cited by 418 · cited 4×
“Prior to initiating statin therapy, plasma aminotransferases, CK, glucose, and creatinine should be measured [8, 19, 20, 22, 65, 148, 149].”
BackgroundInfluentialSafety considerations with fibrate therapy
Davidson, M. H., Armani, A., McKenney, J. M., & Jacobson, T. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.016 · Cited by 408
Raal, F. J., Pilcher, G. J., Panz, V. R., van Deventer, H. E., Brice, B. C., Blom, D. J., & Marais, A. D. (2011) · Circulation · doi:10.1161/circulationaha.111.042523 · Cited by 366
Self-citationKoren, M. J., Scott, R., Kim, J. B., Knusel, B., Liu, T., Lei, L., Bolognese, M., & Wasserman, S. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61771-1 · Cited by 366
Eckel, R. H., Jakicic, J. M., Ard, J. D., Jesus, J. M. D., Miller, N. H., Hubbard, V. S., Lee, I.-M. M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 354
Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
Raal, F. J., & Santos, R. D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.019 · Cited by 349
Self-citationWriting Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051bab · Cited by 343
Leebmann, J., Roeseler, E., Julius, U., Heigl, F., Spitthoever, R., Heutling, D., Breitenberger, P., Maerz, W., Lehmacher, W., Heibges, A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002432 · Cited by 329
Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia
Wiegman, A., de Groot, E., Hutten, B. A., Rodenburg, J., Gort, J., Bakker, H. D., Sijbrands, E. J., & Kastelein, J. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15467-6 · Cited by 324
Self-citationJansen, A. C. M., van Aalst‐Cohen, E. S., Tanck, M. W., Trip, M. D., Lansberg, P. J., Liem, A. H., Roeters van Lennep, H. W. O., Sijbrands, E. J. G., & Kastelein, J. J. P. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01405.x · Cited by 302
Self-citationStein, E. A., Dufour, R., Gagne, C., Gaudet, D., East, C., Donovan, J. M., Chin, W., Tribble, D. L., & McGowan, M. (2012) · Circulation · doi:10.1161/circulationaha.112.104125 · Cited by 301
Stein, E. A., Honarpour, N., Wasserman, S. M., Xu, F., Scott, R., & Raal, F. J. (2013) · Circulation · doi:10.1161/circulationaha.113.004678 · Cited by 300
Self-citationThrombotic Stroke and Myocardial Infarction With Hormonal Contraception
Lidegaard, Ø., Løkkegaard, E., Jensen, A., Skovlund, C. W., & Keiding, N. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000422965.64164.ac · Cited by 292
Statin Treatment in Children With Familial Hypercholesterolemia: The Younger, the Better
Rodenburg, J., Vissers, M. N., Wiegman, A., van Trotsenburg, A. S. P., van der Graaf, A., de Groot, E., Wijburg, F. A., Kastelein, J. J. P., & Hutten, B. A. (2007) · Circulation · doi:10.1161/circulationaha.106.671016 · Cited by 286
Self-citationEngelen, L., Ferreira, I., Stehouwer, C. D., Boutouyrie, P., Laurent, S., & on behalf of the Reference Values for Arterial Measurements Collaboration (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs380 · Cited by 286
Recommendations for the use of LDL apheresis
Thompson, G. R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.009 · Cited by 270
Safety considerations with niacin therapy
Guyton, J. R., & Bays, H. E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.018 · Cited by 269
Statins for children with familial hypercholesterolemia
Vuorio, A., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., Drogari, E., & Ramaswami, U. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub4 · Cited by 265
Self-citationAn Assessment of Statin Safety by Muscle Experts
Thompson, P. D., Clarkson, P. M., & Rosenson, R. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.013 · Cited by 259
Diagnosis and treatment of familial hypercholesterolaemia
Hovingh, G. K., Davidson, M. H., Kastelein, J. J. P., & O'Connor, A. M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht015 · Cited by 256
Self-citationCho, I., Chang, H.-J., Sung, J. M., Pencina, M. J., Lin, F. Y., Dunning, A. M., Achenbach, S., Al-Mallah, M., Berman, D. S., Budoff, M. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.081380 · Cited by 248
Avis, H. J., Vissers, M. N., Stein, E. A., Wijburg, F. A., Trip, M. D., Kastelein, J. J. P., & Hutten, B. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.145151 · Cited by 241
Self-citationPijlman, A. H., Huijgen, R., Verhagen, S. N., Imholz, B. P. M., Liem, A. H., Kastelein, J. J. P., Abbink, E. J., Stalenhoef, A. F. H., & Visseren, F. L. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.014 · Cited by 238
Self-citationNiacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227 · cited 3×
“hepatotoxic and myotoxic [118, 119], although in practice the chances of severe toxicity are extremely low.”
BackgroundMcGowan, M. P., Tardif, J.-C., Ceska, R., Burgess, L. J., Soran, H., Gouni-Berthold, I., Wagener, G., & Chasan-Taber, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049006 · Cited by 224
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia
Marks, D., Wonderling, D., Thorogood, M., Lambert, H., Humphries, S. E., & Neil, H. A. W. (2002) · BMJ · doi:10.1136/bmj.324.7349.1303 · Cited by 217
Sijbrands, E. J. G., Kaprio, J., Westendorp, R. G. J., Defesche, J. C., de Meier, P. H. E. M., Smelt, A. H. M., & Kastelein, J. J. P. (2001) · BMJ · doi:10.1136/bmj.322.7293.1019 · Cited by 216
Self-citationNational Standards for Diabetes Self-Management Education and Support
Haas, L., Maryniuk, M., Beck, J., Cox, C. E., Duker, P., Edwards, L., Fisher, E. B., Hanson, L., Kent, D., Kolb, L., et al. (2013) · Diabetes Care · doi:10.2337/dc13-s100 · Cited by 206
Managing Dyslipidemia in Chronic Kidney Disease
Harper, C. R., & Jacobson, T. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.025 · Cited by 204
Familial hypercholesterolaemia: A model of care for Australasia
Watts, G. F., Sullivan, D. R., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P. M., O’Brien, R., Bishop, W., George, P., Barter, P. J., et al. (2011) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2011.06.001 · Cited by 204
Self-citationUsifo, E., Leigh, S. E. A., Whittall, R. A., Lench, N., Taylor, A., Yeats, C., Orengo, C. A., Martin, A. C. R., Celli, J., & Humphries, S. E. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00724.x · Cited by 201
Marteau, T., Senior, V., Humphries, S. E., Bobrow, M., Cranston, T., Crook, M. A., Day, L., Fernandez, M., Horne, R., Iversen, A., et al. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30102 · Cited by 194
Self-citationParental History and Myocardial Infarction Risk Across the World
Chow, C. K., Islam, S., Bautista, L. E., Rumboldt, Z., Yusufali, A., Xie, C., Anand, S. S., Engert, J. C., Rangarajan, S., & Yusuf, S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.054 · Cited by 191
Gidding, S. S., Lichtenstein, A. H., Faith, M. S., Karpyn, A., Mennella, J. A., Popkin, B., Rowe, J., Van Horn, L., & Whitsel, L. (2009) · Circulation · doi:10.1161/circulationaha.109.191856 · Cited by 190
Self-citationStatin Safety and Drug Interactions: Clinical Implications
Bottorff, M. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.007 · Cited by 188
Taylor, A., Wang, D., Patel, K., Whittall, R., Wood, G., Farrer, M., Neely, R., Fairgrieve, S., Nair, D., Barbir, M., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01356.x · Cited by 188
Neil, H. A. W. (2000) · BMJ · doi:10.1136/bmj.321.7254.148 · Cited by 186
Wald, D. S., Bestwick, J. P., & Wald, N. J. (2007) · BMJ · doi:10.1136/bmj.39300.616076.55 · Cited by 184
Suthers, G. K., Armstrong, J., McCormack, J., & Trott, D. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.039172 · Cited by 183
Kolansky, D. M., Cuchel, M., Clark, B. J., Paridon, S., McCrindle, B. W., Wiegers, S. E., Araujo, L., Vohra, Y., Defesche, J. C., Wilson, J. M., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.035 · Cited by 181
Self-citationGuidelines for the Management of Familial Hypercholesterolemia
Harada-Shiba, M., Arai, H., Oikawa, S., Ohta, T., Okada, T., Okamura, T., Nohara, A., Bujo, H., Yokote, K., Wakatsuki, A., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14621 · Cited by 176
Self-citationTreatment strategies in patients with statin intolerance: the Cleveland Clinic experience
Mampuya, W. M., Frid, D., Rocco, M., Huang, J., Brennan, D. M., Hazen, S. L., & Cho, L. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.06.004 · Cited by 173
Daniels, S. R., Gidding, S. S., & de Ferranti, S. D. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.03.453 · Cited by 172
Self-citationGenetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics
Recommendations of the European Society of Human Genetics (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.26 · Cited by 167
Where are we with probucol: A new life for an old drug?
Yamashita, S., & Matsuzawa, Y. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.002 · Cited by 167
Self-citationStarr, B., Hadfield, S. G., Hutten, B. A., Lansberg, P. J., Leren, T. P., Damgaard, D., Neil, H. A. W., & Humphries, S. E. (2008) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2008.135 · Cited by 165
Universal Versus Targeted Blood Cholesterol Screening Among Youth: The CARDIAC Project
Ritchie, S. K., Murphy, E., Lilly, C. L., Cottrell, L., Minor, V. E., Elliott, E. M., & Neal, W. A. (2010) · PEDIATRICS · doi:10.1542/peds.2009-2546 · Cited by 165
Nherera, L. M., Marks, D., Minhas, R., Thorogood, M., & Humphries, S. E. (2011) · Heart · doi:10.1136/hrt.2010.213975 · Cited by 162
Integrating quality into the cycle of therapeutic development
Califf, R. M., Peterson, E. D., Gibbons, R. J., Garson, A., Brindis, R. G., Beller, G., & Smith, S. C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02537-8 · Cited by 161
Non-adherence to statin therapy: a major challenge for preventive cardiology
Bates, T., Connaughton, V., & Watts, G. F. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903376186 · Cited by 155
Self-citationDescamps, O. S., Tenoutasse, S., Stéphenne, X., Gies, I., Beauloye, V., Lebrethon, M.-C., de Beaufort, C. E., Waele, K. D., Scheen, A. J., Rietzschel, E. R., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.016 · Cited by 153
Ito, M. K., McGowan, M. P., & Moriarty, P. M. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.04.001 · Cited by 151
Amundsen, Å. L., Ose, L., Nenseter, M. S., & Ntanios, F. Y. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.338 · Cited by 148
Family History and Cardiovascular Risk in Familial Hypercholesterolemia
Wiegman, A., Rodenburg, J., de Jongh, S., Defesche, J. C., Bakker, H. D., Kastelein, J. J. P., & Sijbrands, E. J. G. (2003) · Circulation · doi:10.1161/01.cir.0000058166.99182.54 · Cited by 142
Self-citationMata, N., Rodrigo Alonso, K., Badimón, L., Padró, T., Fuentes, F. J., Muñiz-Grijalvo, O., Pérez‐Jiménez, F., López‐Miranda, J., Díaz-Díaz, J. L., Vidal, J. I., et al. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-94 · Cited by 140
Self-citationVeerkamp, M. J., Graaf, J. D., Hendriks, J. C. M., Demacker, P. N. M., & Stalenhoef, A. F. H. (2004) · Circulation · doi:10.1161/01.cir.0000130646.93255.86 · Cited by 139
Moruisi, K. G., Oosthuizen, W., & Opperman, A. M. (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719513 · Cited by 136
Ast, M., & Frishman, W. H. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03447.x · Cited by 135
Senior, V., Marteau, T. M., Weinman, J. A., & Genetic Risk Assessment for FH Trial (GRAFT) Study Group (2004) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-004-6225-z · Cited by 130
Robinson, J. G., & Goldberg, A. C. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.451 · Cited by 123
Hormone therapy and risk of myocardial infarction: a national register study
Løkkegaard, E., Andreasen, A. H., Jacobsen, R. K., Nielsen, L. H., Agger, C., & Lidegaard, Ø. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn408 · Cited by 120
Statin use during pregnancy: a systematic review and meta-analysis
Kusters, D. M., Lahsinoui, H. H., van der Post, J., Wiegman, A., Wijburg, F. A., Kastelein, J. J. P., & Hutten, B. A. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.196 · Cited by 113
Self-citationSevere hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
Thompson, G. R., Catapano, A. L., Saheb, S., Atassi, M., Barbir, M., Eriksson, M., Paulweber, B., Sijbrands, E. J. G., Stalenhoef, A. F. H., & Parhofer, K. G. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283402f53 · Cited by 107
Self-citationClaassen, L., Henneman, L., Kindt, I., Marteau, T. M., & Timmermans, D. R. M. (2010) · Journal of Health Psychology · doi:10.1177/1359105309345170 · Cited by 106
Molecular Basis of Autosomal Dominant Hypercholesterolemia
van der Graaf, A., Avis, H. J., Kusters, D. M., Vissers, M. N., Hutten, B. A., Defesche, J. C., Huijgen, R., Fouchier, S. W., Wijburg, F. A., Kastelein, J. J. P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.979450 · Cited by 106
Self-citationAntisense oligonucleotides for the treatment of dyslipidaemia
Visser, M. E., Witztum, J. L., Stroes, E. S. G., & Kastelein, J. J. P. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs084 · Cited by 105
Self-citationGidding, S. S., Bookstein, L. C., & Chomka, E. V. (1998) · Circulation · doi:10.1161/01.cir.98.23.2580 · Cited by 103
Self-citationMotazacker, M. M., Pirruccello, J. P., Huijgen, R., Do, R., Gabriel, S., Peter, J., Kuivenhoven, J. A., Defesche, J. C., Kastelein, J. J. P., Hovingh, G. K., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs010 · Cited by 101
Self-citationI Diretriz Brasileira de Hipercolesterolemia Familiar (HF)
Santos, R., Gagliardi, A., Xavier, H. T., Filho, A. C., Araújo, D., Cesena, F., Alves, R., Pereira, A., Lotemberg, A., Chacra, A., et al. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20120202 · Cited by 99
Self-citationAllen, J. K., Himmelfarb, C. D., Szanton, S. L., & Frick, K. D. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3182945243 · Cited by 98
Vuorio, A. F., Docherty, K. F., Humphries, S. E., Kuoppala, J., & Kovanen, P. T. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.032 · Cited by 97
Hadfield, S. G., Horara, S., Starr, B. J., Yazdgerdi, S., Marks, D., Bhatnagar, D., Cramb, R., Egan, S., Everdell, R., Ferns, G., et al. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008094 · Cited by 97
Hudgins, L. C., Kleinman, B. M., Scheuer, A., White, S., & Gordon, B. R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.06.049 · Cited by 88
Approach to the Patient Who Is Intolerant of Statin Therapy
Eckel, R. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2689 · Cited by 88
Psychological Issues in Genetic Testing for Inherited Cardiovascular Diseases
Aatre, R., & Day, S. M. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.957365 · Cited by 86
Paediatric screening for hypercholesterolaemia in Europe: Table 1
Kusters, D. M., de Beaufort, C. E., Widhalm, K., Guardamagna, O., Bratina, N., Ose, L., & Wiegman, A. (2011) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-300081 · Cited by 84
Self-citationThe evaluation of cascade testing for familial hypercholesterolemia
Morris, J. K., Wald, D. S., & Wald, N. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34368 · Cited by 81
What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?
Humphries, S. E., Norbury, G., Leigh, S. E. A., Hadfield, S. G., & Nair, D. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830636e5 · Cited by 80
Genetic analysis of familial hypercholesterolaemia in Western Australia
Hooper, A. J., Nguyen, L., Burnett, J. R., Bates, T. R., Bell, D. A., Redgrave, T. G., Watts, G. F., & BOCKXMEER, F. M. V. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.030 · Cited by 80
Self-citationAdemi, Z., Watts, G. F., Juniper, A., & Liew, D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.280 · Cited by 80
Self-citationSeidah, N. G. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990313 · Cited by 77
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Strandberg, T. E., Tonstad, S., & Gylling, H. K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub2 · Cited by 77
Buchwald, H., Rudser, K. D., Williams, S. E., Michalek, V. N., Vagasky, J., & Connett, J. E. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181deb4d0 · Cited by 76
Lipoprotein apheresis: State of the art and novelties
Stefanutti, C., & Julius, U. (2013) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2012.10.021 · Cited by 76
Græsdal, A., Bogsrud, M. P., Holven, K. B., Nenseter, M. S., Narverud, I., Langslet, G., Brekke, M., Retterstøl, K., Arnesen, K.-E., & Ose, L. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.03.004 · Cited by 74
Khoury, M. J., Coates, R. J., & Evans, J. P. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f9ad55 · Cited by 72
Kassim, S. H., Li, H., Bell, P. L., Somanathan, S., Lagor, W. R., Jacobs, F., Billheimer, J. T., Wilson, J. M., & Rader, D. J. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.108 · Cited by 72
Venero, C. V., & Thompson, P. D. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.002 · Cited by 71
Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia
Harada-Shiba, M., Sugisawa, T., Makino, H., Abe, M., Tsushima, M., Yoshimasa, Y., Yamashita, T., Miyamoto, Y., Yamamoto, A., Tomoike, H., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4143 · Cited by 70 · cited 2×
“Statins reduce the risk for cardiovascular events [108-113] and”
BackgroundLDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives
Al-Allaf, F. A., Coutelle, C., Waddington, S. N., David, A. L., Harbottle, R. P., & Themis, M. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-36 · Cited by 70
Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance
Thorogood, M., Seed, M., Mott, K. D., & Guideline Development Group (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.02084.x · Cited by 69
Opportunistic screening for familial hypercholesterolaemia via a community laboratory
Bell, D. A., Hooper, A. J., Bender, R., McMahon, J., Edwards, G., BOCKXMEER, F. M. V., Watts, G. F., & Burnett, J. R. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012002 · Cited by 69
Self-citationBell, D. A., Garton‐Smith, J., Vickery, A. W., Kirke, A. B., Pang, J., Bates, T. R., & Watts, G. F. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2013.08.005 · Cited by 68
Self-citationElis, A., Zhou, R., & Stein, E. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.027 · Cited by 68
Merz, C. N. B., Alberts, M. J., Balady, G. J., Ballantyne, C. M., Berra, K. A., Black, H. R., Blumenthal, R. S., Davidson, M. H., Fazio, S. B., Ferdinand, K. C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.019 · Cited by 66
Preemptive liver transplantation in a child with familial hypercholesterolemia
Maiorana, A., Nobili, V., Calandra, S., Francalanci, P., Bernabei, S. M., Hachem, M. E., Monti, L., Gennari, F., Torre, G., de Goyet, J. D. V., et al. (2010) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2010.01383.x · Cited by 65
Palcoux, J., Atassi, M., Lefèvre, P., Héquet, O., Schlienger, J.-L., Brignon, P., & Roussel, B. (2008) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2008.00574.x · Cited by 65
CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia
Neefjes, L. A., ten Kate, G. R., Rossi, A., Galema-Boers, A. J., Langendonk, J. G., Weustink, A. C., Moelker, A. D., Nieman, K., Mollet, N. R., Krestin, G. P., et al. (2011) · Heart · doi:10.1136/hrt.2010.220699 · Cited by 64
Self-citationIdentification and management of familial hypercholesterolaemia: what does it mean to primary care?
Qureshi, N., Humphries, S. E., Seed, M., Rowlands, P., Minhas, R., & on behalf of the NICE Guideline Development Group (2009) · British Journal of General Practice · doi:10.3399/bjgp09x472674 · Cited by 63
Microsomal transfer protein inhibition in humans
Cuchel, M., & Rader, D. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32836139df · Cited by 62
Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring
van der Graaf, A., Vissers, M. N., Gaudet, D., Brisson, D., Sivapalaratnam, S., Roseboom, T. J., Jansen, A. C. M., Kastelein, J. J. P., & Hutten, B. A. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209064 · Cited by 62
Self-citationLiver transplantation for inherited metabolic disorders of the liver
Moini, M., Mistry, P. K., & Schilsky, M. L. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283399dbd · Cited by 60
The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease
Thompson, G. R. (2013) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2012.10.001 · Cited by 59
Drug Treatment of Hyperlipidaemia: A Guide to the Rational Use of Lipid-Lowering Drugs
Toth, P. P. (2010) · Drugs · doi:10.2165/10898610-000000000-00000 · Cited by 57
Self-citationAhmad, Z., ADAMS-HUET, B. A., Chen, C., & Garg, A. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.963587 · Cited by 57
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
Hamilton-Craig (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s13496 · Cited by 56
Junyent, M., Gilabert, R., Jarauta, E., Núñez, I., Cofán, M., Civeira, F., Pocoví, M., Mallén, M., Zambón, D., Almagro, F., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.058 · Cited by 56
Current view: indications for extracorporeal lipid apheresis treatment
The German Apheresis Working Group, Schettler, V. J. J., Neumann, C. L., Hulpke‐Wette, M., Hagenah, G. C., Schulz, E. G., & Wieland, E. (2012) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-012-0046-6 · Cited by 53
Stefanutti, C., Lanti, A., Giacomo, S. D., Mareri, M., Lorenzo, F., Landolfo, A., & Isacchi, G. (2004) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2004.01.010 · Cited by 53
Nherera, L. M., Calvert, N., DeMott, K., Humphries, S. E., Neil, H. A. W., Minhas, R., & Thorogood, M. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903494934 · Cited by 52
Datta, B. N., McDowell, I. F. W., & Rees, A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833c14e2 · Cited by 51
Homozygous Familial Hypercholesterolemia and Its Management
Marais, A. D., Firth, J. C., & Blom, D. J. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-822985 · Cited by 50
Clinical Lipidology: A Companion to Braunwald's Heart Disease
van Heyningen, C. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.200917 · Cited by 49
Drug Therapy of Hypercholesterolaemia in Children and Adolescents
Braamskamp, M. J. A. M., Wijburg, F. A., & Wiegman, A. (2012) · Drugs · doi:10.2165/11632810-000000000-00000 · Cited by 48
Self-citationClarke, R. E., Padayachee, S. T., Preston, R., McMahon, Z., Gordon, M., Graham, C. A., Crook, M. A., & Wierzbicki, A. S. (2012) · Heart · doi:10.1136/heartjnl-2012-302917 · Cited by 47
Self-citationIbrahim, M. E., El-Hamamsy, I., Barbir, M., & Yacoub, M. H. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9311-1 · Cited by 45
Ooi, E. M. M., Barrett, P. H. R., & Watts, G. F. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.069 · Cited by 42
Self-citationHuijgen, R., Vissers, M. N., Kindt, I., Trip, M. D., de Groot, E., Kastelein, J. J. P., & Hutten, B. A. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.959239 · Cited by 42
Self-citationOptimal management of familial hypercholesterolemia: treatment and management strategies
Nemati, M. H., & Astaneh, B. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s8283 · Cited by 42
Broekhuizen, K., Jelsma, J. G. M., van Poppel, M. N. M., Lando Koppes, L. J., Brug, J., & van Mechelen, W. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-348 · Cited by 42
Detection of Familial Hypercholesterolaemia: A Major Treatment Gap in Preventative Cardiology
Bates, T. R., Burnett, J. R., BOCKXMEER, F. M. V., Hamilton, S. J., Arnolda, L., & Watts, G. F. (2007) · Heart Lung and Circulation · doi:10.1016/j.hlc.2007.06.005 · Cited by 41
Self-citationTaylor, A., Martín, B., Wang, D., Patel, K., Humphries, S. E., & Norbury, G. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01168.x · Cited by 38
Avis, H. J., Kusters, D. M., Vissers, M. N., Huijgen, R., Janssen, T. H., Wiegman, A., Kindt, I., Kastelein, J. J. P., Wijburg, F. A., & Hutten, B. A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.037 · Cited by 35
Self-citationCoexisting dysbetalipoproteinemia and familial hypercholesterolemia
Carmena, R., Roy, M., Roederer, G. O., Minnich, A., & Davignon, J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00212-9 · Cited by 33
Hadfield, S. G., Horara, S., Starr, B. J., Yazdgerdi, S., Bhatnagar, D., Cramb, R., Egan, S., Everdell, R., Ferns, G. A., Jones, A. F., et al. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2007.007078 · Cited by 33
Langslet, G., & Ose, L. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.814851 · Cited by 32
Role of international registries in enhancing the care of familial hypercholesterolaemia
Hammond, E., Watts, G. F., Rubinstein, Y., Farid, W., Livingston, M., Knowles, J. W., Lochmüller, H., Bellgard, M., & Dawkins, H. J. S. (2013) · International Journal of Evidence-Based Healthcare · doi:10.1111/1744-1609.12023 · Cited by 32
Self-citationGoldberg, A. C., Robinson, J. G., Cromwell, W. C., Ross, J. L., & Ziajka, P. E. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.04.002 · Cited by 32
Familial hypercholesterolaemia in children and adolescents: A new paediatric model of care
Martin, A. C., Coakley, J. C., Forbes, D., SULLIVAN, D. R., & Watts, G. F. (2012) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.12036 · Cited by 31
Self-citationNeil, H. A. W., Hammond, T., Mant, D., & Humphries, S. E. (2004) · BMJ · doi:10.1136/bmj.328.7438.500 · Cited by 30
Watts, G. F., Juniper, A., van Bockxmeer, F., Ademi, Z., Liew, D., & O'Leary, P. C. (2012) · International Journal of Evidence-Based Healthcare · doi:10.1111/j.1744-1609.2012.00272.x · Cited by 29
Self-citationAarden, E., Hoyweghen, I. V., & Horstman, K. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811414241 · Cited by 26
Alonso, R., de Bobadilla, J. F., Méndez, I., Lázaro, P., Mata, N., & Mata, P. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60139-5 · Cited by 26
Self-citationVogt, A., & Parhofer, K. G. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.779253 · Cited by 25
Self-citationChanges and Variability in High Levels of Low-Density Lipoprotein Cholesterol Among Children
Freedman, D. S., Wang, Y. C., Dietz, W. H., Xu, J., Srinivasan, S. R., & Berenson, G. S. (2010) · PEDIATRICS · doi:10.1542/peds.2009-3454 · Cited by 25
Familial hypercholesterolemia in children and adolescents
McCrindle, B. W. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283587522 · Cited by 24
New therapies to reduce low-density lipoprotein cholesterol
Wierzbicki, A. S., Viljoen, A., Hardman, T. C., & Mikhailidis, D. P. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283605fa2 · Cited by 24
Self-citationLow-density lipoprotein apheresis: an evidence-based analysis.
(2007) · PubMed · Cited by 24
Recent advances in the treatment of homozygous familial hypercholesterolaemia
Marais, A., & Blom, D. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32836308bc · Cited by 22
Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe
Mata, N., Rodrigo Alonso, K., Banegas, J. R., Zambón, D., Brea, Á., & Mata, P. (2012) · European Journal of Public Health · doi:10.1093/eurpub/cks174 · Cited by 22
Self-citationTiyyagura, S. R., & Smith, D. A. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.001 · Cited by 21
Lombardi, M. P., Redeker, E. J. W., Gent, D. H. M. V., Smeele, K. L., Weerdesteijn, R., & Mannens, M. M. A. M. (2006) · Genetic Testing · doi:10.1089/gte.2006.10.77 · Cited by 19
Cited by
Cuchel, M., Bruckert, E., Ginsberg, H. N., Raal, F. J., Santos, R. D., Hegele, R. A., Kuivenhoven, J. A., Nordestgaard, B. G., Descamps, O. S., Steinhagen-Thiessen, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu274 · Cited by 1,057
Self-citationWiegman, A., Gidding, S. S., Watts, G. F., Chapman, M. J., Ginsberg, H. N., Cuchel, M., Ose, L., Averna, M., Boileau, C., Borén, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv157 · Cited by 891
Self-citationRaal, F. J., Stein, E. A., Dufour, R., Turner, T., Civeira, F., Burgess, L., Langslet, G., Scott, R., Olsson, A. G., Sullivan, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61399-4 · Cited by 756
Self-citationWorldwide Prevalence of Familial Hypercholesterolemia
Beheshti, S. O., Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.057 · Cited by 625
Clinical Genetic Testing for Familial Hypercholesterolemia
Sturm, A. C., Knowles, J. W., Gidding, S. S., Ahmad, Z. S., Ahmed, C. D., Ballantyne, C. M., Baum, S. J., Bourbon, M., Carrié, A., Cuchel, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.044 · Cited by 615
Self-citation
Metadata
- Authors
- Watts, G. F., Gidding, S., Wierzbicki, A. S., Toth, P. P., Alonso, R., Brown, W. V., Bruckert, E., Defesche, J., Lin, K. K., Livingston, M., Mata, P., Parhofer, K. G., Raal, F. J., Santos, R. D., Sijbrands, E. J. G., Simpson, W. G., Sullivan, D. R., Susekov, A. V., Tomlinson, B., Wiegman, A., Yamashita, S., & Kastelein, J. J. P.
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 171
- Issue
- 3
- Pages
- 309-325
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W2016805353
- Cited by
- 377
- References
- 210
- FWCI
- 40.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.